Artículos de revistas
Postprandial Hyperglycemia: Treating Its Atherogenic Potential [hiperglicemia Pós-prandial: Tratamento Do Seu Potencial Aterogênico]
Registro en:
Arquivos Brasileiros De Cardiologia. , v. 87, n. 5, p. 604 - 613+660-670, 2006.
0066782X
10.1590/S0066-782X2006001800018
2-s2.0-33846369855
Autor
Geloneze B.
Lamounier R.N.
Coelho O.R.
Institución
Resumen
[No abstract available] 87 5 604 613+660-670 De Fronzo, R.A., Lilly lecture 1987. The triumvirate: Beta cell, muscle, liver. A collusion responsible for IDDM (1988) Diabetes, 37, pp. 667-687 Stratton, I.M., Adler, A.I., Neil, H.A., Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study (2000) BMJ, 321, pp. 405-412 Standards of care for patients with diabetes mellitus (Position Statement) (2004) Diabetes Care, (SUPPL. 1), pp. S15-S35. , American Diabetes Association Glucose tolerance and cardiovascular mortality (2001) Arch Intern Med, 161, pp. 397-405. , DECODE Study Group Dinneen, S., Gerich, J., Rizza, R., Carbohydrate metabolism in non-insulin dependent diabetes mellitus (1992) N Engl J Med, 327, pp. 707-713 Gavin III, J.R., Pathophysiologic mechanisms of postprandial hyperglycemia (2001) Am J Cardiol, 88 (SUPPL. 1), pp. 4H-8H Lebovitz HE. A Symposium: Managing the atherogenic potential of the postprandial state. Am J Cardiol 2001 88(Suppl 1): 1H-3HMeyer, U., Gressner, A.M., Endocrine regulation of energy metabolism: Review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin (2004) Clinical Chemistry, 50 (9), pp. 1511-1525 Polonsky, K.S., Given, B.D., Hirsch, L.J., Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus (1988) N Engl J Med, 318, pp. 1231-1239 Hall, L.D., Westland, R.E., Effects of size, time of day and sequence of meal ingestion on carbohydrate tolerance in normal subjects (1983) Diabetologia, 25, pp. 316-321. , Service FJ Yaney, G.C., Corkey, B.E., Fatty acid metabolism and insulin secretion in pancreatic beta cells (2003) Diabetologia, 46 (10), pp. 1297-1212 Kahn, S.E., The importance of beta-cell in the pathogenesis of type 2 diabetes melitus (2000) Am J Med, 108, pp. 2S-8S Poitout, V., Robertson, R.P., Minireview: Secondary beta-cell failure in type 2 diabetes: a convergence of glucotoxicity and lipotoxicity (2002) Endocrinology, 143, pp. 339-342 McKillop AM, Abdel-Wahab YH, Mooney MH, et al. Secretion of glycated insulin from pancreatic beta-cells in diabetes represents a novel aspect of beta-cell dysfunction and glucose toxicity. Diabetes Metab 2002 28: 3S61-69Visboll, T., Holst, J.J., Incretins, insulin secretion and Type 2 diabetes mellitus (2004) Diabetologia, 47 (3), pp. 357-366 Bruce, D.G., Storlien, L.H., Furler, S.M., Chisholm, D.J., Cephalic phase metabolic responses in normal weight adults (1987) Metabolism, 36, pp. 721-725 Mitrakou, A., Kelley, D., Mokan, M., Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance (1992) N Engl J Med, 326, pp. 22-29 Luzi, L., De Fronzo, R.A., Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans (1989) Am J Physiol, 257, pp. E241-E246 Consoli, A., Nurjhan, N., Capani, F., Gerich, J., Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM (1989) Diabetes, 38, pp. 550-557 Del Prato, S., Marchetti, P., Bonadonna, R.C., Phasic insulin release and metabolic regulation in type 2 diabetes (2002) Diabetes, 51 (SUPPL. 1), pp. S109-S116 Weyer, C., Borgadus, C., Mott, D.M., Pratley, R.E., The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus (1999) J Clin Invest, 104, pp. 787-794 Freskens, E.J., Kromhout, D., Glucose tolerance and the risk of cardiovascular disease: The Zutphen Study (2001) J Clin Epidemiol, 54, pp. 869-876 Haffner, S.M., Lehto, S., Ronnemma, T., Mortality from coronary artery disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction (1998) N Engl J Med, 339, pp. 229-234 Avezum, A., Piegas, L.S., Pereira, J.C.R., Risk factors associated with acute miocardial infarction in the São Paulo metropolitan region. A developed region in a developing country (2005) Arq Bras Cardiol, 84 (3), pp. 206-213 Moraes, S.A., de Souza, J.M., Diabetes Mellitus and ischemic heart disease. Comparison by gender (1996) Arq Bras Cardiol, 66 (2), pp. 59-63 Matsubara, B.B., Okoshi, K., Okoshi, M.P., Arterial dysfunction as a possible mechanism of cardiac injury in type. A Doppler-echocardiographic study (1997) Arq Bras Cardiol, 69 (3), pp. 155-159 Kannel, W.B., McGee, D.L., Diabetes and cardivascular disease. The Framingham study (1979) JAMA, 241, pp. 2035-2038 Stamler, J., Vaccaro, O., Neaton, J.D., Wentworth, D., Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Interventional Trial (1993) Diabetes Care, 16, pp. 434-444 Lee, W.L., Cheung, A.M., Cape, D., Zinman, B., Impact of diabetes on coronary artery disease in women and men: A meta-analysis of prospective studies (2000) Diabetes Care, 23, pp. 962-968 Intensive blood-glucose control with sulphonylurea or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) (1998) Lancet, 352, pp. 837-853. , UK Prospective Diabetes Study Group Laakso, M., Hyperglycemia and cardiovascular disease in type 2 diabetes (1999) Diabetes, 48, pp. 937-942 De Vegt, F., Dekker, J.M., Ruhè, H.G., Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: The Hoorn Study (1999) Diabetologia, 42, pp. 926-931 Donahue, R.P., Abbott, R.D., Reed, D.M., Yano, K., Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry: Honolulu Heart Program (1987) Diabetes, 36, pp. 689-692 Glucose tolerance and mortality: Comparison of WHO and American Diabetes Association diagnostic criteria (1999) Lancet, 354, pp. 617-621. , The DECODE Study Group, the European Diabetes Epidemiology Group Coutinho, M., Gerstein, H.C., Wang, Y., Yusuf, S., The relationship between glucose and incident cardiovascular events: A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years (1999) Diabetes Care, 22, pp. 233-240 Fuller, J.H., Shipley, M.J., Rose, G., Coronary heart disease risk and impaired glucose tolerance: The Whitehall Study (1980) Lancet, 8183, pp. 1373-1376 Fontbonne, A., Eschwege, E., Cambien, F., Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study (1989) Diabetologia, 32 (5), pp. 300-304 Pyorala, K., Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: Results from two population studies in Finland (1979) Diabetes Care, 2 (2), pp. 131-141 Bahia, L., Gomes, M.B., da Cruz, P.D.M., Gonçalves, M.D.F., Coronary artery disease, microalbuminuria and lipid profile in patients with non-insulin dependent diabetes mellitus (1999) Arq Bras Cardiol, 73 (1), pp. 11-22 Zilversmidt, D.B., Atherogenesis: A postprandial phenomenon (1979) Circulation, 60, pp. 473-485 Groot, P.H.E., Van Stiphout, W.A.H.J., Krauss, X.H., Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease (1991) Arterioscler Thromb, 11, pp. 653-662 Patsch, J.R., Miesenböck, G., Hopferwieser, T., Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state (1992) Arterioscler Thromb, 12, pp. 1336-1345 Mamo, J.C.L., Proctor, S.D., Smith, D., Retention of chylomicron remnants by arterial tissue importance of an efficient clearance mechanism from plasma (1998) Atherosclerosis, 141 (SUPPL.), pp. S63-S69 Miesenböck, G., Patsch, J.R., Postprandial hyperlipidemia: The search for the atherogenic lipoprotein (1992) Curr Opin Lipidol, 3, pp. 196-201 Ginsberg, H.N., Lipoprotein physiology in nondiabetic and diabetic states: Relationship to atherogenesis (1991) Diabetes Care, 14, pp. 839-855 Ginsberg, H.N., Lipoprotein physiology (1998) Endocrinol Metabol Clin North Am, 27, pp. 503-519 Pastch, J., Influence of lipolysis on chylomicron clearance and HDL cholesterol levels (1998) Eur Heart J, 19 (SUPPL. H), pp. H2-H6 Ginsberg, H.N., Illingworth, D.R., Postprandial dyslipidemia: An atherogenic disorder common on patients with diabetes mellitus.Am (2001) J Cardiol, 11 (SUPPL.), pp. 4H-8H Daughert, Y.A., Lange, L.G., Sobel, B.E., Schonfeld, G., Aortic accumulation and plasma clearance of beta-VLDL and HDL: Effects of diet-induced hypercholesterolemia in rabbits (1985) J lipid Res, 16, pp. 955-963 Rapp, J.H., Lespine, A., Hamilton, R.L., Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosortion from human atherosclerotic plaque (1994) Artherioscler Thromb, 14, pp. 1767-1774 Cohn, J.S., Oxidized fat in the diet, postprandial lipaemia and cardiovascular disease (2002) Current Opinion in Lipidology, 13 (1), pp. 19-24 Frayn, K.N., Insulin resistance, impaired postprandial lipid metabolism and abdominal obesity. A deadly triad (2002) Med Princ Pract, 11 (SUPPL. 2), pp. 31-40 Lebovitz, H.E., Effect of the postprandial state on nontraditional risk factors.Am (2001) J Cardiol, 88 (SUPPL.), pp. 20H-25H Haller, H., Postprandial glucose and vascular disease (1997) Diabetic Medicine, 14, pp. S50-S56 Giuliano, D., Marfella, R., Coppola, L., Vascular effects of acute hyperglycemia in humans are reversed by L-arginine: Evidence for reduced availability of nitric oxide during hyperglycemia (1997) Circulation, 95, pp. 1783-1790 Heine, R.J., Dekker, J.M., Beyond postprandial hyperglycaemia: Metabolic factors associated with cardiovascular disease (2002) Diabetologia, 45, pp. 461-475 Lee, I.K., Kim, H.S., Bae, J.H., Endothelial dysfunction: Its relantionship with acute hyperglycemia and hyperlipidemia (2002) Int J Clin Pract, 129 (SUPPL.), pp. 59-64 Marfella, R., Verrazzo, G., Acampora, R., Glutathione reverses systemic hemodynamic changes by acute hyperglycemia in healthy subjects (1995) Am J Physiol, 268, pp. E1167-E1173 Beckman, J.A., Goldfine, A.B., Gordon, M.B., Creager, M.A., Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans (2001) Circulation, 103, pp. 1618-1623 Ceriello, A., Quagliaro, L., Piconi, L., Effect of postprandial hypertrigliceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment (2004) Diabetes, 53, pp. 701-710 Ceriello, A., Giugliano, D., Quatraro, A., Blood glucose may condition factor VII levels in diabetic and normal subjects (1988) Diabetologia, 31, pp. 889-891 Ceriello, A., Giacomello, R., Stel, G., Hyperglycemia-induced thrombin formation in diabetes: The possible role of the oxidative stress (1995) Diabetes, 44, pp. 924-928 Sakamoto, T., Ogawa, H., Kawano, H., Rapid change of platelet aggregability in acute hyperglycemia: Detection by a novel laser-light scattering method (2000) Thromb Haemost, 83, pp. 475-479 Jones, R.L., Peterson, C.M., Reduced fibrinogen survival in diabetes mellitus a reversible phenomenon (1979) J Clin Invest, 63, pp. 485-493 Ceriello, A., Falleti, E., Motz, E., Hyperglycemia-induced circulating ICAM-1 increase in diabetes mellitus: The possible role of oxidative stress (1998) Horm Metab Res, 30, pp. 146-149 Marfella, R., Esposito, K., Giunta, R., Circulating adhesion molecules in humans: Role of hyperglycemia and hyperinsulinemia (2000) Circulation, 101, pp. 2247-2251 Van Osostrom, A.J.H.H.M., Sijmonsma, T.P., Verseyden, C., Postprandial recruitment of neutrophils may contribuye to endotelial dysfunction (2003) J Lipid Res, 44, pp. 576-583 Woerle, H.J., Pimenta, W.P., Meyer, C., Diagnostic and therapeutic implications of relationships between fasting, 2-hour postchallenge plasma glucose and hemoglobin A1c values (2004) Arch Intern Med, 164, pp. 1627-1632 The American Association of Clinical Endocrinologists Medical Guidelines for the Management of Diabetes Mellitus: The AACE System of Intensive Diabetes Self-Management. Endocr Pract 2002 8 Suppl 1, 40-82Consenso Brasileiro sobre Diabetes 2002. Diagnóstico e classificação do diabetes melito e tratamento do diabetes melito do tipo 2. Rio de Janeiro: Diagraphic Editora 2003De Venciana Major, C.A., Morgan, M.A., Tamerou, A., Toohey, J.S., Lien, J.M., EVANS, A.T., Postprandial versus preprandial blood glucose monitoring in women with gestacional diabetes mellitus requiring insulin therapy (1995) N Engl J Med, 333, pp. 1237-1241 Bastyr, E.J., Stuart, C.A., Brodows, R.G., Therapy Focused on Lowering Postprandial Glucose, Not Fasting Glucose, May be Superior for Lowering HbA1c (2000) Diabetes Care, 23, pp. 1236-1241 Monnier, L., Lapinski, H., Colette, C., Contributions of fasting and postprandial plasma glucose increments to overall diurnal hyperglycemia of type 2 diabetic patients (2003) Diabetes Care, 26, pp. 881-885 Larsen, J.J., Dela, F., Kjaer, M., Galvo, H., The effect of intense exercise on postprandial glucose homeostasis in type 2 diabetic patients (1999) Diabetologia, 42, pp. 1282-1292 Poirier, P., Mawhinney, S., Grondin, L., Prior meals enhances the plasma glucose lowering effect exercise in type 2 diabetes (2001) Med Sci Sports Exerc, 33, pp. 1259-1264 Gill, J.M.R., Hardman, A.E., Postprandial lipemia: Effects of exercise and restriction of energy intake compared (2000) Am J Clin Nutr, 71, pp. 465-471 Wolever, T.M., Bolgnesi, C., Source and amount of carbohydrate affect postprandial glucose and insulin in normal subjects (1996) J Nutr, 126, pp. 2798-2806 Brenelli, S.L., Campos, S.D.S., Saad, M.J.A., Viscosity of gums in vitro and their ability to reduce postprandial hyperglycemia in normal subjects (1997) Brazilian J Med and Biol Res, 30, pp. 1437-1440 Sheard, N.F., Clark, N.G., Brand-Miller, J.C., Dietary carbohydrate (amount and type) in the prevention and management of diabetes. A Statement by the American Diabetes Association (2004) Diabetes Care, 27 (9), pp. 2266-2271 Hu, F.B., Willet, W.C., Optimal diets for prevention of coronary heart disease (2002) JAMA, 288, pp. 2569-2578 Freiberg, M.S., Cabral, H.J., Heeren, T.C., Alcohol Consumption and the prevalence of the Metabolic Syndrome in the U.S (2004) Diabetes Care, 27, pp. 2954-2959 Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin (2002) N Engl J Med, 346, pp. 393-403. , Diabetes Prevention Program Research Group Clark, H.E., Mattews, D.R., The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus (1996) Horm Metab Res, 28, pp. 445-450 Ashcroft, F.M., Mechanisms of the glycaemic effercts of sulfonylureas (1996) Horm Metab Res, 28, pp. 456-463 Shapiro, E.T., Van Cauter, E., Tillil, H., Glyburide enhances the responsiveness of the beta cell to glucose but does not correct the abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus (1989) J Clin Endocrinol Metab, 69, pp. 571-576 Dabrowski, M., Wahl, P., Holmes, W.E., Ashcroft, F.M., Effect of repaglinide on cloned beta cell, cardiac and smooth muscle types of ATP-sensitive potassium channels (2001) Diabetologia, 44, pp. 747-756 Dornhorst, A., Insulinotropic meglitinide analogues (2001) Lancet, 358, pp. 1709-1716 Nattrass, M., Lauritzen, T., Review of prandial glucose regulation with repaglinide: A solution to the problem of hypoglycaemia in the treatment of Type 2 diabetes? (2000) International Journal of Obesity, 24 (SUPPL. 3), pp. S21-S31 Tankova, T., Dragomir, K., Dakovska, L., KiriloVG, The effect of repaglinide on insulin secretion and oxidative stress in type 2 diabetic patients (2003) Diab Res Clin Pract, 59, pp. 43-49 Hanefeld, M., Bouter, K.P., Dickinson, S., Guitard, C., Rapid and short-acting mealtime insulin secretion with nateglinide controls both prandial and mean glycemia (2000) Diabetes Care, 23, pp. 202-207 Inzucchi, S.E., Oral Antihyperglycemic Therapy for Type 2 Diabetes. Scientific Review (2002) JAMA, 287, pp. 360-372 Bailey, C., Biguanides and NIDD (1992) Diabetes Care, 15 (2), pp. 755-772 Bailey, C.J., Turner, R.C., Metformin (1996) N Engl J Med, 334, pp. 574-579 Fery, F., Plat, L., Balasse, E.O., Effects of metformin on the pathways of glucose utilization after oral glucose in non-insulin-dependent diabetes mellitus patients (1997) Metabolism, 46 (2), pp. 227-233 Effect of intensive glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) (1998) Lancet, 352, pp. 854-865. , UK Prospective Diabetes Study Group Day, C., Thiazolidinediones: A new class of antidiabetic drugs (1999) Diabetic Med, 16, pp. 1-14 Rosen, E.D., Spiegelman, B.M., PPAR-γ: A nuclear regulator of metabolism, differentiation, and cell growth (2001) J Biol Chem, 276, pp. 37731-37734 Raskin, P., Rappaport, E.B., Cole, S.T., Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with Type II diabetes (2000) Diabetologia, 43, pp. 278-284 Fonseca, V., Grunberger, G., Gupta, S., Addition of nateglinide to rosiglitazone monotherapy suppresses mealtime hyperglycemia and improves overall glycemic control (2003) Diabetes Care, 26 (6), pp. 1685-1690 Lebovitz, H.E., Alfa-Glucosidase inhibitors as agents in the treatment of diabetes (1998) Diabetes Revs, 6, pp. 132-145 Holman RR, Cull CA, Turner RC on Behalf of The UKPDS Study GROUP. A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44). Diabetes Care 1999 22(6): 960-4Hirsh, I.B., Insulin Analogues (2005) N Engl J Med, 352, pp. 174-183 Evans, M., Anderson, R.A., Smith, J.C., Khan, N., Effects of insulin lispro and chronic vitamin C therapy on postprandial lipaemia, oxidative stress and endothelial function in patients with type 2 diabetes mellitus (2003) Europ J Clin Invest, 33, pp. 231-238 Ceriello, A., Cavarape, A., Martinelli, L., The post-prandial state in Type 2 diabetes and endothelial dysfunction: Effects of insulin aspart (2004) Diabet Med, 21, pp. 171-175 Hermansen, K., Colombo, M., Storgaard, H., Improved postprandial glycemic control with biphasic insulin aspart relative to biphasic human insulin in patients with type 2 diabetes (2002) Diabetes Care, 25 (5), pp. 883-888 Raskin, P., Allen, E., Hollander, P., Initiating insulin therapy in type 2 diabetes: A comparison of biphasic and basal insulin analogs (2005) Diabetes Care, 28 (2), pp. 260-265 Odegard, P.S., Capoccia, K.L., Inhaled Insulin: Exubera (2005) Ann Pharmacother, 39, pp. 843-853 Turner, R.C., Cull, C.A., Frighi, V., Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirements for multiple therapies (1999) JAMA, 281, pp. 2005-2012 Vuskan, V., Sievenpiper, J.L., Koo, V.Y.Y., American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus (2000) Arch Intern Med, 160, pp. 1009-1013 Levetan, C., Want, L.L., Weyer, C., Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagons, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps (2003) Diabetes Care, 26, pp. 1-8 Weyer, C., Gottleb, A., Kim, D.D., Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes (2003) Diabetes Care, 26, pp. 3074-3079 Edwards, C.M., Stanley, S.A., DaVis, R., Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers (2001) Am J Physiol Endocrinol Metab, 281, pp. E155-E161 Juhl, C.B., Hollingdal, M., Sturis, J., Bedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes (2002) Diabetes, 51, pp. 424-429 Kolterman, O.G., Buse, J.B., Fineman, M.S., Synthetic Exendin-4 (Exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes (2003) J Clin Endocrinol Metab, 88, pp. 3082-3089 Ahrén, B.O., Simonsson, E., Larsson, H., Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes (2002) Diabetes Care, 25, pp. 869-875